Delivery Order SPE2DB20D2104-SPE2DB24FS20B

Award Date 1/24/24
Potential Completion Date 1/25/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIBERZI 100 MG TABLET 60S, a pharmaceutical product, valued at $1,427.00. The contract has an ultimate completion date of May 21, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,249.97 and runs through July 19, 2024. It is for the delivery of VIBERZI 100 MG TABLET 60S, a pharmaceutical product, to support federal healthcare programs. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.63 firm fixed-price delivery order covers the supply of VIBERZI 100 MG TABLET 60S, a pharmaceutical product, with a period of performance through February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.04 firm-fixed-price delivery order is for the supply of VIBERZI 100 MG TABLET 60S, with an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a Firm Fixed Price delivery order for $1,650.57 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564514361 - VIBERZI 100 MG TABLET 60S, with a period of performance ending on May 7, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,219.52 firm fixed-price delivery order is for the supply of 4566847560 VIBERZI 100 MG TABLET 60S, a medication used in the treatment of certain medical conditions. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,395.87, is for the supply of VIBERZI 100 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of December 31, 2024. This contract is not a set-aside, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,707.63, is a delivery order for the pharmaceutical product VIBERZI 75 MG TABLET 60S. The contract has a firm fixed price pricing type and an ultimate completion date of January 9, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,607.03 Firm Fixed Price delivery order contract is for the supply of 4562597804 - VIBERZI 75 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of October 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 60 tablets of the pharmaceutical product VIBERZI 75 MG, with a potential value of $2,474.72 and a completion date of February 8, 2024. This delivery order contract falls under a larger indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FS20B
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIBERZI 100 MG TABLET 60S. The contract has a ceiling value of $1,792.65 and an ultimate completion date of January 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:06 AM